| 标题 |
[求助补充材料]
Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised study |
| 备注 |
仅需POD1UM-304本文官方Supplementary appendix(mmc1.pdf,约3.10 MB),含随附方案/SAP如有。 正文已有,无需正文。DOI 10.1016/s2213-2600(25)00209-7
💡 该求助存在备注,如果存在信息冲突,请以备注为准
|
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)